Does Rallies show LCTX price targets?

Yes. Rallies tracks LCTX analyst ratings, consensus rating, average price target, upgrades, downgrades, analyst firms, and recent price target changes when available.

Is LCTX research on Rallies investment advice?

No. Rallies provides research, data, and educational context for LCTX. It does not provide personalized investment advice.

LCTX (Lineage Cell Therapeutics, Inc.) Stock Analysis - Analyst Ratings

Lineage Cell Therapeutics, Inc. (LCTX) is a publicly traded Healthcare sector company. As of September 8, 2026, LCTX trades at $1.11 with a market cap of $273.14M and a P/E ratio of -7.71. LCTX moved +2.59% today. Year to date, LCTX is -35.33%; over the trailing twelve months it is -11.48%. Its 52-week range spans $0.37 to $2.09. Analyst consensus is strong buy with an average price target of $7.00. Rallies surfaces LCTX's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

What do analysts rate LCTX?

4 analysts cover LCTX: 0 strong buy, 4 buy, 0 hold, 0 sell, and 0 strong sell. The consensus rating is strong buy. The average price target is $7.00.

LCTX Key Metrics

Key financial metrics for LCTX
Metric	Value
Price	$1.11
Market Cap	$273.14M
P/E Ratio

EPS	$-0.14

Dividend Yield	0.00%

52-Week High	$2.09

52-Week Low	$0.37

Volume	131.11K

Avg Volume	0

Revenue (TTM)	$13.08M

Net Income	$-32.10M

Gross Margin	0.00%

Common questions about LCTX

What do analysts rate LCTX?: 4 analysts cover LCTX: 0 strong buy, 4 buy, 0 hold, 0 sell, and 0 strong sell. The consensus rating is strong buy. The average price target is $7.00.
Does Rallies show LCTX price targets?: Yes. Rallies tracks LCTX analyst ratings, consensus rating, average price target, upgrades, downgrades, analyst firms, and recent price target changes when available.
Is LCTX research on Rallies investment advice?: No. Rallies provides research, data, and educational context for LCTX. It does not provide personalized investment advice.

Lineage Cell Therapeutics

Analysts

Lineage Cell Therapeutics

Analysts

LCTX Analyst Consensus

Common questions about LCTX